Related references
Note: Only part of the references are listed.Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
Piotr Adamski et al.
JOURNAL OF CLINICAL MEDICINE (2022)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study
Matthias K. Freynhofer et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Dirk Sibbing et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis
Fabio Mangiacapra et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study)
Bjorn Redfors et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Evening intake of aspirin is associated with a more stable 24-h platelet inhibition compared to morning intake: a study in chronic aspirin users
Jeske Joanna Katarina van Diemen et al.
PLATELETS (2016)
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study
Fabio Mangiacapra et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
Platelet Function and Inhibition in Ischemic Heart Disease
Annunziata Nusca et al.
CURRENT CARDIOLOGY REPORTS (2012)
Circadian Variation in Coronary Stent Thrombosis
Karim D. Mahmoud et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease
E. L. Grove et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Diurnal variation in platelet inhibition by clopidogrel
Marek Kozinski et al.
PLATELETS (2011)
Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularization
Fabio Mangiacapra et al.
BIOMARKERS IN MEDICINE (2010)
Point-of-Care Assessment of Platelet Reactivity After Clopidogrel to Predict Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention
Fabio Mangiacapra et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
High Residual Platelet Reactivity After Clopidogrel Extent of Coronary Atherosclerosis and Periprocedural Myocardial Infarction in Patients With Stable Angina Undergoing Percutaneous Coronary Intervention
Fabio Mangiacapra et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Circadian Variation within Hemostasis: An Underrecognized Link between Biology and Disease?
Martina Montagnana et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention - Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) Study
Giuseppe Patti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Triggering of acute cardiovascular disease and potential preventive strategies
Geoffrey H. Tofler et al.
CIRCULATION (2006)
Share Paper
